ImmunityBio

ImmunityBio is a brand dedicated to revolutionizing cancer treatment. They develop innovative therapies that target and kill the disease without compromising the immune system. Their investigational immunotherapy and cell therapy products are at the forefront of medical advancements. Through their unique approach, ImmunityBio aims to outsmart diseases such as cancer and HIV. They offer personalized immunotherapies that strengthen the patient's immune system, enabling it to effectively fight against cancerous or infected cells. By focusing on strengthening the immune system, ImmunityBio's therapies minimize the weakening effects commonly associated with traditional cancer treatments like chemotherapy and radiation therapy. In addition to their cutting-edge therapies, ImmunityBio is committed to increasing diversity in clinical trials to address healthcare disparities. They collaborate with trial investigators and researchers to discover and develop future cancer treatments. With a robust clinical pipeline, ImmunityBio is at the forefront of immunotherapy research and development. Their goal is to conquer diseases like cancer and HIV, making fear of these diseases a thing of the past.